1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,077 | 0,118 | 02.06. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | hVIVO schließt Beratungsvertrag mit Decoy Therapeutics | 2 | Investing.com Deutsch | ||
| Mo | hVIVO PLC - Consultancy contract with Decoy Therapeutics | - | RNS | ||
| Fr | hVIVO PLC - Grant of awards under Long Term Incentive Plan | - | RNS | ||
| 20.05. | hVIVO PLC - Capital Markets Day | - | RNS | ||
| 13.05. | hVIVO PLC - Result of AGM | 1 | RNS | ||
| 12.05. | hVIVO PLC - Holding(s) in Company | - | RNS | ||
| 07.05. | EARNINGS AND TRADING: MHA expects profit beat; hVIVO wins work | 1 | Alliance News | ||
| 07.05. | hVIVO signs £6m influenza clinical trial deal | 1 | Sharecast | ||
| HVIVO Aktie jetzt für 0€ handeln | |||||
| 07.05. | hVIVO PLC - £6m Influenza HCT contract signed | - | RNS | ||
| 24.04. | hVIVO PLC - Director/PDMR Shareholding | - | RNS | ||
| 22.04. | hVIVO secures large whooping cough vaccine test contract | 1 | Sharecast | ||
| 22.04. | hVIVO PLC - HCT contract signed with ILiAD Biotechnologies | - | RNS | ||
| 17.04. | hVIVO PLC - Annual Report & Notice of AGM | 1 | RNS | ||
| 15.04. | EARNINGS AND TRADING: hVIVO swings to pretax loss after expansion | 1 | Alliance News | ||
| 15.04. | hVIVO PLC - Final Results 2025 | - | RNS | ||
| 14.04. | hVIVO PLC - hVIVO launches unified brand identity | - | RNS | ||
| 14.04. | hVIVO PLC - Influenza HCT contract signed with Traws Pharma | 1 | RNS | ||
| 07.04. | hVIVO PLC - Notice of Results | - | RNS | ||
| 26.03. | hVIVO PLC - Holding(s) in Company | 1 | RNS | ||
| 23.02. | hVIVO PLC - Issue of Equity and Total Voting Rights | - | RNS |
1 2 Weiter >>
26 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NUGEN MEDICAL DEVICES | 0,012 | -21,52 % | NuGen Medical Devices Inc.: NuGen Medical Devices Files Patent for Dual Spring Technology Enhancing Needle-Free Injection Performance | Toronto, Ontario--(Newsfile Corp. - May 28, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen" or the "Company"), a leader in needle free drug delivery, today announced the filing of a new... ► Artikel lesen | |
| PLUS THERAPEUTICS | 4,805 | -1,84 % | Plus Therapeutics Inc.: Plus' CNSide Diagnostic Platform Demonstrates Substantial Healthcare Cost Reduction in Patients with Leptomeningeal Metastases | ||
| UNIDOC HEALTH | 0,062 | +3,32 % | UniDoc Health Corp.: UniDoc Reflects on Successes One Year After AMD Telemedicine Software Purchase | AMD Telemedicine software and related systems now fully integrated; UniDoc Connect used at more than 800 sites across 48 countries VANCOUVER, BC / ACCESS Newswire / May 21, 2026 / UniDoc Health Corp.... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,038 | -19,15 % | Mountain Valley MD Holdings Inc: Mountain Valley MD appoints advisers, grants options | ||
| JD HEALTH INTERNATIONAL | 4,256 | -1,03 % | JD HEALTH Repurchases 2.53M Shares on Thu for HKD96.92M | ||
| MEDIVOLVE | - | - | Medivolve Inc (2): OSC cites Bharti, Said for disclosure failures | ||
| LIFEWARD | 7,680 | -3,40 % | Lifeward Ltd.: Lifeward Appoints Dr. Keith D. Rose as Chief Medical Officer to Support Expansion of Neurorehabilitation Portfolio and Advance Biomed Platform | Veteran physician- medical affairs and clinical research leader brings 30 years of rehabilitation medicine experience and deep expertise in neuroscience- mobility technologies, and metabolic disease... ► Artikel lesen | |
| LIGHT AI | 0,180 | +9,45 % | Photonics Theme Gains Momentum In ETF Market As GraniteShares Files 'Speed Of Light AI ETF' | ||
| IMUNON | 1,800 | 0,00 % | Imunon, Inc.: IMUNON Reports 2025 Financial Results and Provides Business Update Highlighting Significant Progress with Pivotal Phase 3 Study | IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly diagnosed with advanced ovarian cancer Final Phase 2... ► Artikel lesen | |
| ROCKWELL MEDICAL | 0,615 | -0,81 % | H.C. Wainwright reiterates Rockwell Medical stock rating on contract wins | ||
| IMAGIN MEDICAL | 0,001 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 15.05.2026 | The following instruments on Boerse Frankfurt do have their last trading day on 15.05.2026.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 15.05.2026.ISIN NameCA2985962067 EUREKA... ► Artikel lesen | |
| VIRIDIAN THERAPEUTICS | 14,700 | +0,68 % | Viridian Therapeutics, Inc.\DE - 8-K, Current Report | ||
| AROVELLA THERAPEUTICS | 0,039 | 0,00 % | AROVELLA THERAPEUTICS LIMITED: Notification of cessation of securities - ALA | ||
| MEMPHASYS | 0,002 | 0,00 % | Memphasys inks maiden South-East Asian commercialisation agreement | ||
| PREVECEUTICAL MEDICAL | 0,012 | 0,00 % | PreveCeutical Medical Inc.: PreveCeutical Announces Extension of Non-Brokered Private Placement | Vancouver, British Columbia--(Newsfile Corp. - May 19, 2026) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H0) (the "Company" or "PreveCeutical"), is pleased to announce that,... ► Artikel lesen |
HVIVO PLC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,002 (+2,38 %) liegt der Kurs bei 0,086 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu HVIVO PLC finden Sie auf Wallstreet Online.